PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH
| Autor: | Schmidt, WE, Christiansen, JS, Hammer, M, Zychma, MJ, Buse, J |
|---|---|
| Zdroj: | In Value in Health 2009 12(3):A105-A105 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect